Eledon Pharmaceuticals has released updated findings from an investigator-initiated islet transplant trial at UChicago Medicine, focusing on the potential of Tegoprubart in treating Type 1 Diabetes. The new data marks a key step forward for transplant-based research in diabetes care.

Families fighting type 1 diabetes may soon see relief from a high-stakes financial burden. A bipartisan bill aimed at lowering the cost of insulin offers fresh hope, highlighted by the story of a Mississippi toddler who relies on pricey monthly supplies.

Metformin, a commonly discussed medication in diabetes care, does not improve insulin resistance in Type 1 patients, according to a recent report. This finding may influence future considerations about its role for those managing Type 1 diabetes.